We are pleased to release the summary report from the Bellberry & ASCEPT New Approach Methodologies (NAMs) Introductory Workshop, held in Melbourne, 30 Nov 2024.
The report captures insights from regulators, ethicists, researchers, and industry leaders on how Australia can support the responsible use of NAMs to reduce reliance on animal models, improve translational outcomes, and support the transition into first-in-human and early clinical trials.
It outlines:
- Drivers for NAMs adoption
- Validation, regulatory, and ethical considerations
- Therapeutic scenarios explored to test the role of NAMs
- Key priorities for policy, funding, and collaboration